ArticleAnnals of internal medicine2020

Assessing the Risk for Gout With Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes: A Population-Based Cohort Study.

Michael Fralick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.